GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Brodie Mitchell, 20, now admits that his comment was “poorly expressed and inappropriate.”...
Several prominent scientists and researchers in the U.S. have reportedly died or gone missing over the past year, fueling speculation...
“Breathing is a little painful. I feel bruising from the seat belt that I had just from the impact.”...
